파킨슨병과 다계통 위축증 환자들에서 후각기능 및 후각기능과 심장 123I-MIBG섭취율과의 연관성 = Olfactory Function and Its Correlation with Cardiac 123I-MIBG in Patients with Parkinson’s Disease and Multiple System Atrophy

참고문헌 (Reference)

1 "et al. Imaging the primate adrenal medulla with [123I] and [131I] meta-iodobenzylguanidine" 358-364,

2 "editors. Recent developments in Parkinson's disease. Florham Park" Macmillan Healthcare Information 153-163, 1987

3 "Wieland DM. Comparison of the sodium dependency of uptake of meta-lodobenzylguanidine and norepinephrine into cultured bovine adrenomedullary cells. Mol Pharmacol 1984" 539-546,

4 "The anterior olfactory nucleus in Parkinson's disease" 10 : 283-287, 1995

5 "Subclinical dopaminergic dysfunction in asymptomatic Parkinson's disease patients' relatives with a decreased sense of smell" 50 : 34-41, 2001

6 "Stellar S. Olfactory dysfunction in parkinsonism a general deficit unrelated to neurologic signs" 1237-1244,

7 "Staging of brain pathology related to sporadic Parkinson's disease" 24 : 197-211, 2003

8 "Physiology of olfaction" Louis: Mosby year book 844-897, 2004

9 Hoehn MM, Yahr MD, "Parkinsonism: onset, progression and mortality" 17 : 427-442, 1967

10 "Olfactory function in idiopathic Parkinson's disease (IPD): results from cross-sectional studies in IPD patients and long-term follow-up of de-novo IPD patients" 109 : 805-811, 2002

11 "Olfactory function in atypical parkinsonian syndromes" 91 : 247-250, 1995

12 "Olfactory dysfunction in familial parkinsonism" 49 : 1262-1267, 1997

13 "Olfactory bulb in multiple system atrophy" 18 : 938-942, 2003

14 "Olfaction in neurodegenerative disorder" 63 : 133-151, 2006

15 "Olfaction in neurodegenerative disorder" 18 : 364-372, 2003

16 "Olfaction dysfunction in Parkinson's disease" 62 : 436-446, 1997

17 "Marsden CD. Olfactory threshold in Parkinson's disease. J Neurol Neurosurg Psychiatry 1987" 88-89,

18 "Loss of olfaction in de novo and treated Parkinson's disease: possible implications for early diagnosis" 16 : 41-46, 2001

19 "Loss of 123I-metaiodobenzylguanidine (MIBG) uptake by the heart in Parkinson's disease: assessment of cardiac sympathetic denervation and diagnostic value" 40 : 371-375, 1999

20 "Lewy body-type degeneration in cardiac plexus in Parkinson's and incidental Lewy body diseases" 52 : 1269-1271, 1999

21 "Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinsonism-a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992" 181-184.

22 "Johnson A. Olfactory function in patients with Parkinson's disease. J Chron Dis 1975" 493-497,

23 "Is Parkinson's disease a primary olfactory disorder?" 92 : 473-480, 1999

24 "Idiopathic hyposmia as a preclinical sign of Parkinson's disease" 56 : 173-181, 2004

25 "Identifying the pattern of olfactory deficits in parkinson disease using the brief smell identification test" 60 : 545-549, 2003

26 "Identifying the pattern of olfactory deficits in Parkinson disease using the brief smell identification test" 60 : 545-549, 2003

27 "Identifying the pattern of olfactory deficits in Parkinson disease using the brief smell identification test" 60 : 545-549, 2003

28 "Hurtig HI. Bilateral olfactory dysfunction in early stage treated and untreated idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry 1992" 138-142,

29 "Hawkes CH. Preliminary diagnosis of Parkinson's disease using olfactory bulb pathology. Lancet 1992" 186-,

30 "FP-CIT and MIBG scintigraphy in early Parkinson's disease" 20 : 552-561, 2005

31 "Differentiation of Parkinson's disease and multiple system atrophy in early disease stages by means of I-123-MIBG-SPECT" 175 : 3-12, 2000

32 "Development of the 12-Item Cross-Cultural Smell Identification Test (CC-SIT)" 106 : 353-356, 1996

33 "Consensus statement on the diagnosis of multiple system atrophy" 163 : 94-98, 1999

34 "Cardiac uptake of [123I]MIBG separates Parkinson's disease from multiple system atrophy" 53 : 1020-1025, 1999

35 "Cardiac 123I-MIBG scintigraphy can assess the disease severity and phenotype of PD" 220 : 105-111, 2004

36 "Calne DB. Olfactory impairment in Parkinson's disease. Neurology 1983" 943-946,